Martin Jacko

Martin Jacko

Company: Aperture Therapeutics

Job title: Chief Executive Officer


Embracing Genetic Diversity of iPSC-based Neuroinflammation Models for Robust Drug Discovery 12:10 pm

• Developing iPSC panels to account for distinct disease origins and diverse patient genomic background in drug discovery • Leveraging data on protective genomic variants to bolster prioritization of therapeutically relevant disease modifiers • Catalyzing discovery of neuroinflammation modulators for neurodegeneration using therapeutic oligonucleotidesRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.